Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000062X2
CNY
60.42
1.27 (2.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
473.98
330.89
308.86
254.16
342.78
327.27
264.75
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
473.98
330.89
308.86
254.16
342.78
327.27
264.75
Raw Material Cost
67.04
125.34
84.05
87.25
86.38
108.79
72.03
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.29
0.28
0.28
0.28
0.31
0.30
Selling and Distribution Expenses
74.40
68.92
63.03
69.08
75.37
95.53
66.09
Other Expenses
11.50
10.12
7.09
9.04
9.47
8.59
4.46
Total Expenditure (Excl Depreciation)
256.41
295.73
218.26
247.03
256.73
290.55
183.04
Operating Profit (PBDIT) excl Other Income
217.60000000000002
35.2
90.60000000000001
7.1
86.1
36.7
81.7
Other Income
13.12
32.14
16.81
23.54
25.18
12.24
16.56
Operating Profit (PBDIT)
224.32
95.95
138.88
59.44
140.48
81.45
130.70
Interest
0.00
0.29
0.28
0.28
0.28
0.31
0.30
Exceptional Items
9.54
13.40
9.15
19.52
4.30
-0.29
5.41
Gross Profit (PBDT)
406.95
205.55
224.81
166.91
256.40
218.48
192.72
Depreciation
0.00
31.03
31.03
31.48
31.48
32.50
32.50
Profit Before Tax
233.85
78.03
116.72
47.19
113.01
48.35
103.31
Tax
23.33
-9.51
9.97
-5.75
7.99
2.91
11.11
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
208.54
87.37
102.96
471.53
103.54
38.39
91.12
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
208.54
87.37
102.96
471.53
103.54
38.39
91.12
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-4.59
-1.73
-2.84
-2.89
-5.15
-2.78
-2.36
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
203.95
85.64
100.12
468.64
98.39
35.61
88.76
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,898.69
5,698.91
5,671.32
5,567.64
5,073.55
4,992.27
4,988.18
Earnings per share (EPS)
0.34
0.14
0.17
0.76
0.17
0.06
0.15
Diluted Earnings per share
0.34
0.14
0.17
0.76
0.17
0.06
0.15
Operating Profit Margin (Excl OI)
44.56%
9.91%
29.47%
1.73%
24.45%
11.21%
30.84%
Gross Profit Margin
49.34%
32.96%
47.84%
30.95%
42.15%
24.7%
51.3%
PAT Margin
44.0%
26.4%
33.33%
185.52%
30.21%
11.73%
34.42%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 38.27% vs 35.60% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 107.22% vs 49.77% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 83.17% vs 37.10% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -100.00% vs 0.00% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
473.98
0
473.98
Other Operating Income
0.00
0.00
0.00
Total Operating income
473.98
0
473.98
Raw Material Cost
67.04
0
67.04
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
74.40
0
74.40
Other Expenses
11.50
0.00
11.50
Total Expenditure (Excl Depreciation)
256.41
0
256.41
Operating Profit (PBDIT) excl Other Income
217.57
0.00
217.57
Other Income
13.12
0
13.12
Operating Profit (PBDIT)
224.32
0
224.32
Interest
0.00
0
0.00
Exceptional Items
9.54
0
9.54
Gross Profit (PBDT)
406.95
0
406.95
Depreciation
0.00
0
0.00
Profit Before Tax
233.85
0
233.85
Tax
23.33
0
23.33
Provisions and contingencies
0
0
0.00
Profit After Tax
208.54
0
208.54
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
208.54
0
208.54
Share in Profit of Associates
0
0
0.00
Minority Interest
-4.59
0
-4.59
Other related items
0.00
0.00
0.00
Consolidated Net Profit
203.95
0
203.95
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,898.69
0
5,898.69
Earnings per share (EPS)
0.34
0
0.34
Diluted Earnings per share
0.34
0
0.34
Operating Profit Margin (Excl OI)
44.56%
0%
0.00
44.56%
Gross Profit Margin
49.34%
0%
0.00
49.34%
PAT Margin
44.00%
0%
0.00
44.00%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 47.40 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 43.25% vs 7.12% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 38.27% vs 35.60% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 20.39 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 138.20% vs -14.49% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 107.22% vs 49.77% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 21.12 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 231.03% vs -47.75% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 83.17% vs 37.10% in Sep 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 44.56%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024